欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是

中国临床药理学与治疗学 ›› 2013, Vol. 18 ›› Issue (8): 907-909.

• 药物治疗学 • 上一篇    下一篇

绝经对女性舒芬太尼术后镇痛效果的影响

董锡臣1, 黄宇光2   

  1. 1中国中医科学院广安门医院麻醉科,北京 100053;
    2中国医学科学院北京协和医院麻醉科,北京 100730
  • 收稿日期:2012-12-04 修回日期:2013-05-27 出版日期:2013-08-26 发布日期:2013-07-31
  • 作者简介:董锡臣,男,医学博士,副教授,从事麻醉与疼痛的临床科研工作。Tel: 010-88001043 E-mail: gamhdongxc@yahoo.cn; 黄宇光,男,教授,博士生导师,从事麻醉与疼痛的临床科研工作。Tel: 010-65295580 E-mail: pumhhyg@yahoo.com.cn

Effects of female menopause on sufentanil postoperative intravenous analgesia after transabdomial hyteromyomectomy

DONG Xi-chen1, HUANG Yu-guang2   

  1. 1Department of Anesthesia, Guanganmen Hospital, China Acadamy of Chinese Medical Science, Beijing 100053,China;
    2Department of Anesthesia, Peking Union Medical College Hospital, Chinese Aademy of Medical Sciences, Beijing 100730, China
  • Received:2012-12-04 Revised:2013-05-27 Online:2013-08-26 Published:2013-07-31

摘要: 目的: 观察女性绝经后雌激素水平变化对舒芬太尼术后镇痛效果的影响。方法: 全麻腹式子宫全切除术患者60 例,ASA I-Ⅱ级,随机分为 2组,绝经期女性组(Ⅰ组)与未绝经期女性组(Ⅱ组),每组30例,两组术后均行病人自控镇痛(PCA)。PCA配置方法:舒芬太尼 100 mg+恩丹西琼 8 mg 以生理盐水配至 100 mL,于手术结束前 30 min 连接静脉镇痛泵,均以 2 mL/h 的速度持续静脉泵输入。记录患者连接止痛泵后4、8、12、24、36、48 h的视觉模拟评分(VAS)、Ramsay镇静评分和不良反应。结果: 两组患者术后VAS评分均小于3,且2组间差异无统计学意义;两组4、8、12、24、36、48 h 的镇静评分<4,相比差异无统计学意义;两组不良反应,呼吸抑制、恶心、呕吐及皮肤瘙痒发生率相比均无统计学差异。结论: 女性绝经前后雌激素水平变化对舒芬太尼术后镇痛效果无显著影响。舒芬太尼用于患者术后镇痛的效果良好,不良反应发生率低,有临床推广价值。

关键词: 舒芬太尼, 镇痛, 绝经, 子宫全切术

Abstract: AIM: To observe the change of female estrogens on effects and side effects of sufentanil for postoperative intravenous analgesia after transabdominal hysteromyomectomy(TAH).METHODS: Sixty patients for TAH,ASA I-II ,were divided into two groups:I (premenopansal group)and Ⅱ(postmenopausal group), with 30 cases each. Sufentanil 100 mg and ondanstrone 8 mg were diluted with saline into 100 mL and continuously infused at the rate of 2 mL/h before 30 min end of operation.Visual analogue scale(VAS),Ramsay sedation scale and side effects were recorded at 4,8, 12,24,36,and 48 h postoperatively.RESULTS: Two groups had no significant difference in analgesic effects and sedation scale,VAS of all groups were below 3, sedation scale of two groups were lower than 4.The incidence of side effects -respiratory depression,nausea,vomiting and pruritus were no significant difference in the two groups.CONCLUSION: The change of female estrogens has no significant effects on sufentanil postoperative intravenous analgesia after TAH. Intravenous sufentanil can produce reliable postoperative analgesia for patients with TAH and with fewer adverse effects.

Key words: Sufentanil, Analgesia, Menopause, TAH

中图分类号: